Role of tryptophan in the pathogenesis of hepatic encephalopathy

Journal of the Pakistan Medical Association

Volumn 58, Issue 2, 2008, Pages 68-70

  Saleem, Darakhshan M ^a   Haider, Saida ^b   Khan, Moona M ^c   Shamsi, Tahir ^d   Haleem, Darakhshan J ^b  

^a SIR SYED UNIVERSITY OF ENGINEERING AND TECHNOLOGY   (Pakistan)

^b UNIVERSITY OF KARACHI   (Pakistan)

^c JINNAH MEDICAL AND DENTAL COLLEGE   (Pakistan)

^d Bismillah Taqee Hospital   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; TRYPTOPHAN; ALBUMINOID;

ACUTE DISEASE; ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; AMINO ACID BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOALBUMINEMIA; LIVER CIRRHOSIS; MALE; PATHOGENESIS; BLOOD; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PATHOPHYSIOLOGY; PILOT STUDY; RISK FACTOR;

ADOLESCENT; ADULT; ALBUMINS; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PILOT PROJECTS; RISK FACTORS; TRYPTOPHAN;

EID: 43049101537     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Greco AV, Mingrone G, Favuzzi A, Bertuzzi A, Gandolfi A, Desmet R et al. Subclinical hepatic encephalopathy: role of Tryptophan binding to albumin and the competition with indole 3-acetic acid. J Investig Med 2000; 48:274-80.
2. Carlsson A, Lindqvist M. Dependence of 5- HT and catecholamine synthesis on concentration of precursor amino acids in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 1978; 303: 157-64.
3. Albrecht J, Jones EA. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J Neurol Sci 1999; 170: 138-46.
4. Laviano A, Cangiano C, Preziosa I, Riggio O, Conversano L, Cascino A, et al. Plasma tryptophan levels and anorexia in liver cirrhosis. Int J Eat disord 1997; 21: 181-6.
5. McMenamy R H. Binding of Indole analogues to human serum albumin: Effects of fatty acids. J Biol Chem 1965; 240: 4235-43.
6. Rosen HM, Yoshimura N, Hodgman JM, Fisher JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977; 72: 483 -7.
7. Mandelson W B. Neurotransmitter and sleep. J Clin Pschiatry 2001; 62: 5-8.
8. Marsden C A. The neuropharmacology of serotonin in the central nervous system. In: Feine JP, Boyer WF, eds. Selection serotonin reuptake inhibitors. Chichester, UK: Johan Wliey & Sons Ltd., 1991, pp 11-36.
9. Bengtsson F, Bugge M, Jonohensen KH, Butterworth RF. Brain tryptophan hydroxylation in the portacaval shunted rats: a hypothesis for the regulation of serotonin turn over in vivo. J Neurochemistry 1991; 56: 1069-74.
10. Lozeva V, Montgomery JA, Tuomisto L, Rocheleau B, Pannunzio M, Huet PM et al. Increased brain serotonin turnover correlates with the degree of shunting and hyperammonemia in rats following variable portal vein stenosis. J Hepatol 2004; 40: 742-8.
11. Yurdaydin C, Hortnagl H, Stiendl P, Zimmermann Singer EA, PifL C et al. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide - induced acute liver failure. Hepatology 1990;12: 695-700.
12. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in Liver Diseases. Vol III New York: Grune & Stratton 1970; pp 282-98.
13. Crone CC, Gabriel GM, Dimartini A. An over view of psychiatric issues in liver diseases for the consultation liaison psychiatrist. Psychosmatics 2006;47;188-205
14. al Mardini H, Harrson EJ, Ince PG, Bartlett K, Rocord CO. Brain indoles in human hepatic encephalopathy. Hepatology 1993; 17: 1033-40.
15. Ono J, Hutson DG, Dombro RS, Levi JU, Livingstone A, Zeppa R. Gastroenterology 1978; 74: 196-200.
16. Basile AS, Saito K, Li Y, Heys MP. The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure. J Neurochem 1995; 64: 2607-14.
17. Cummings MG, James JH, Soethers PB, Keane JM, Foster J, Fischer JE. Regional brain study of indoleamine metabolism in the rat in acute hepatic failure. J Neurochem 1976; 27: 741-6.
18. Leber Magen Darm. Pathogenesis of hepatic encephalopathy. Life Extension 1977; pp 241-54.
19. Haider S, Saleem S, Shameem S, Ahmed SP, Parveen T, Haleem DJ. Is anorexia in thioacetamide-induced cirrhosis related to an altered brain serotonin concentration? Pol J pharmacol 2004; 56: 73-8.
20. Badawy AA. The functions and regulation of tryptophan pyrrolase. Life Sci 1977; 21: 755-68.
21. Barrett RJ, Blackshear MA, Sanders-Bush E. Discriminative stimulus properties of L-5 Hydroxytryptophon behavioral evidence for multiple serotonin receptors. Psychopharmacology (Berl) 1982; 76: 29-35.
22. Fischer JE, Baldessarini RJ. Pathogenesis and therapy of hepatic coma. Prog Liver Dis 1976; 5: 363-97.
23. Grahame-Smith DG, Parfitt AG. Tryptophan transport across the synaptosomal membrane. J Neurochem 1970; 17: 1339-53.
24. Zoli M, Manchesini G, Cecchini L, Dondi C, Blanchi FB, Pisi E. Binding of Tryptophan to albumin in liver cirrhosis: a reappraisal of the problem. Hepatogastroentrology 1981; 28:87-9.
25. Curzon G. Relationship between plasma, CSF and brain tryptophan. J Neural Trans Suppl 1979;15:81-92.